Cargando…
Strategies for immune regulation in iPS cell-based cardiac regenerative medicine
Cardiac regenerative therapy is expected to be a promising therapeutic option for the treatment of severe cardiovascular diseases. Artificial tissues or organoids made from cardiovascular cell lineages differentiated from human induced pluripotent stem cells (iPSCs) are expected to regenerate the da...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523082/ https://www.ncbi.nlm.nih.gov/pubmed/33005258 http://dx.doi.org/10.1186/s41232-020-00145-4 |